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Abstract
Objectives—Controversy surrounds the diagnostic categorization of children with episodic
moods that cause impairment, but do not meet DSM-IV criteria for bipolar I (BD-I) or bipolar II
(BD-II) disorder. This study aims to characterize the degree to which these children, who meet
criteria for bipolar disorder not otherwise specified (BD-NOS), are similar to those with full
syndromal BD, versus those with no bipolar spectrum diagnosis (no BSD).
Methods—Children ages 6–12 years old were recruited from nine outpatient clinics,
preferentially selected for higher scores on a 10-item screen for manic symptoms. Interviews with
the children and their primary caregivers assessed a wide array of clinical variables, as well as
family history.
Results—A total of 707 children (9.4 ± 1.9 years old) were evaluated at baseline, and were
diagnosed with BD-I (n = 71), BD-II (n = 3), BD-NOS (including cyclothymia; n = 88), or no
BSD (n = 545). Compared to BD-I, the BD-NOS group had less severe past functional
impairment. However, current symptom severity and functional impairment did not differ between
BD-NOS and BD-I, even though both groups were significantly more symptomatic and impaired
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than the no BSD group. Parental psychiatric history was similar for BD-NOS and BD-I groups,
and both were more likely than the no BSD group to have a parent with history of mania. Rates of
elated mood did not differ between BD-NOS and BD-I youth.
Conclusions—Children with BD-NOS and BD-I are quite similar, but different from the no
BSD group, on many phenomenological measures. These findings support the hypothesis that BD-
NOS is on the same spectrum as BD-I.
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While full syndromal bipolar disorder (BD) [bipolar I (BD-I) or bipolar II (BD-II) disorder]
is relatively rare in children and adolescents, a much larger proportion of youth have a range
of sub-syndromal spontaneously episodic mood disturbances, and even more have non-
specific manic-type symptoms (1–8). In both adolescents and adults, even mild
subsyndromal manic symptoms have been shown to have important clinical implications,
including a more severe clinical course and a poor response to antidepressants (9–14). An
important diagnostic question is the degree to which these presentations represent a
spectrum of bipolarity, versus distinct disorders with unique clinical characteristics and
trajectories (15, 16).
Many studies have focused on the clinical characteristics, family history, and trajectory of
youth with sub-syndromal episodic mood disturbances. Overwhelmingly, this work has
indicated that these youth have significant functional impairment, comparable with the
degree of impairment seen in major depression or even BD-I and BD-II (6, 13, 17, 18).
However, there is disagreement about whether these youth truly have a variant of BD that
will indeed progress to a full syndromal presentation, and should be treated as such (19, 20).
For example, while clinical samples indicate a high rate of progression from subsyndromal
BD to BD-I or BD-II (on the order of 45% in five years) (12), epidemiologic samples have a
much lower degree of progression (18, 21). Much of this variability likely reflects
methodological differences in the assessment of subsyndromal bipolar symptomatology
across clinical and epidemiologic studies (22), as well as the degree of functional
impairment in these populations (23).
In an effort to identify youth with episodic mood disturbances who did not meet full criteria
for BD-I or BD-II, Axelson et al. (24) operationalized criteria for bipolar disorder not
otherwise specified (BD-NOS) that were then used to recruit participants for the Course and
Outcome of Bipolar Youth (COBY) study. To meet the criteria for BD-NOS, participants
had to have at least four lifetime days (not necessarily consecutive) with at least four hours
of either (i) elated mood plus two associated manic symptoms or (ii) irritable mood plus
three associated manic symptoms. Episodic mood disturbances had to be associated with a
clear change in functioning, could not meet full criteria for a manic or hypomanic episode,
and could not be mainly accounted for by other disorders. (This category includes youth
who meet DSM-IV criteria for cyclothymia.) Using these criteria, several important findings
from the COBY study have emerged. Youth with BD-NOS were shown to have a large
degree of functional impairment, and a high rate of family history of bipolar disorder (24).
Additionally, subsyndromal and syndromal manic episodes did not significantly differ
according to particular symptoms, such as elated versus irritable mood (24). Finally,
longitudinal follow-up has indicated a large degree of progression from BD-NOS to BD-I or
BD-II (45% in five years), with family history being the primary predictor of this
progression (12, 25, 26).
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These data indicate that BD-NOS and BD-I are likely to be along a spectrum of disorder;
however, the question remains whether these results would also apply to a more broadly
defined population of youth with non-specific (and in many cases non-episodic) manic-type
symptoms. The Longitudinal Assessment of Manic Symptoms (LAMS) study provides an
ideal population in which to test the degree to which the COBY findings extend to a
clinically recruited population with less episodic manic-type symptoms. The LAMS study
recruited eligible youth from nine outpatient clinics, disproportionately selecting youth with
manic symptoms which were not necessarily episodic (27, 28). At study entry, less than one-
quarter of the youth fit criteria for bipolar spectrum disorders (BSD), defined as BD-I, BD-
II, or BD-NOS (using COBY criteria, which includes cyclothymia).
Based on previous work, we predicted that youth with BD-NOS and BD-I (who, by
definition, have distinct episodes of manic symptoms) would share several clinical
characteristics, phenomenology, and family history, and that these groups would differ from
youth with no BSD (who do not have distinct episodes of manic symptoms). Specifically,
this paper tested the following hypotheses: (i) we predicted that BD-NOS and BD-I groups
would both have significant functional impairment, and that both groups would be more
impaired than a group with no BSD; (ii) we predicted that BD-NOS and BD-I would show
similar comorbidity, but would differ from the group with no BSD; and (iii) we predicted
that, compared to the no BSD group, the BD-NOS and BD-I groups would have an elevated
parental history of mania. Finally, we conducted an exploratory analysis to assess whether
phenomenology of manic symptomatology (determined by individual characteristics, such




Details of the methods used in the LAMS study have been described elsewhere (28). Briefly,
this study recruited participants through a two-stage approach, designed to select for
elevated symptoms of mania (ESM). A total of 3,329 children (ages 6 years to 12 years and
11 months) were invited to participate in initial screening; these youth were recruited from
nine outpatient clinics in Pittsburgh (PA, USA) and Cincinnati, Columbus, and Cleveland
(OH, USA) that were associated with participating universities. Inclusion criteria were: (i)
age within the specified range and (ii) both child and parent spoke English. Exclusion
criteria were: (i) having a prior visit to a participating outpatient clinic in the past year or (ii)
having a sibling already enrolled in the study.
Parents of 2,622 eligible youth agreed to participate, and completed the Parent General
Behavior Inventory-10 Item Mania Scale (PGBI-10M) (29), a validated screen for elevated
symptoms of mania (ESM). This scale consists of ten items scored on a scale of 0 to 3.
Based on their score, children were classified as ESM+ (score ≥ 12) or ESM- (< 12). All of
the ESM+ children (n = 1,124) were invited to participate; n = 621 agreed and completed a
full assessment. For every 10 ESM+ children recruited, one ESM− youth was asked to
participate (ratio was 5:1 at clinics with a low volume); these ESM− subjects (n = 86) were
matched to the modal ESM+ child at the time of recruitment on demographic factors, and
sampled with replacement. The threshold of 12+ was selected because it was high enough to
enrich the cohort for youth with manic symptoms, but low enough to be only moderately
diagnostically specific, resulting in a study sample with a heterogeneous mix of
presentations.
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Baseline assessments gathered demographic data on participants, including age, sex, race,
ethnicity, and health insurance. Data were also collected on indicators of socioeconomic
status (parents’ education and employment status) and living situation (with both parents
versus not). A complete list of current and past psychotropic medications was also obtained
from the parent/guardian. The Family History Screen (FHS) (30) collected information on
15 psychiatric disorders and suicidal behavior in biological parents.
Interviewers assessed DSM-IV diagnoses by completing an augmented version of the
Schedule for Affective Disorders and Schizophrenia for School-Aged Children–Present and
Lifetime Episode (KSADS-PL) (31) with youths and their parents/guardians. Additional
data regarding depression and manic symptoms were collected using items derived from the
Washington University Kiddie Schedule for Affective Disorders (WASH-U-KSADS) (32),
augmented with items to screen for pervasive developmental disorders. The KSADS
Depression Rating Scale (KDRS) and KSADS Mania Rating Scale (KMRS) provided
filtered ratings of mood symptoms, meaning that symptom severity was measured
exclusively in the context of a mood episode. These ratings were collected for the two-week
period preceding baseline and for the most severe episode in the past.
Criteria for BD-NOS were derived from the Course Outcome of Bipolar Youth (COBY)
study (33). These included: (i) a distinctive period of abnormally elated, irritable, or
expansive mood plus two associated manic symptoms (three if mood is irritable); (ii) an
associated clear change in functioning; (iii) episodes lasting at least four hours in a 24-hour
period for ≥ 4 lifetime days (not necessarily consecutive); and (iv) the child did not meet
criteria for BD-I or BD-II. Note that these criteria would include participants diagnosed with
cyclothymic disorder (14, 34). DSM-IV-TR criteria were used to diagnose BD-I and BD-II,
as well as other psychiatric disorders. All diagnoses were confirmed by a licensed child
psychiatrist or psychologist.
The Young Mania Rating Scale (YMRS) (35, 36) and the Children’s Depression Rating
Scale-Revised (CDRS-R) (37) were also used to assess unfiltered mood symptoms at
baseline. These scales were rated independent of mood state (in a ‘what you see is what you
get’ format). The Children’s Global Assessment Scale (CGAS) (38) was used to provide a
quantitative evaluation of child’s function (at home, school, and with peers). Data on global
functioning were obtained for the two-week period preceding data collection, as well as the
past two-week period with the most severe functional impairment.
Interviewer training and reliability of assessments
Interviewers were trained during an initial three-day meeting, followed by rating
assessments along with taped interviews; interviewers then administered the assessment
instruments. To minimize rater drift, interviewers rated taped administrations of the KSADS
throughout the data collection period. Kappa for all psychiatric diagnoses using this
instrument was 0.82; the kappa for BSD was 0.93 (27).
Statistical analyses
All analyses were conducted using SAS 9.2. First, unadjusted analyses were conducted.
Subsequently, analyses were adjusted for demographic variables associated with BD
diagnosis, using a cut-off p-value of < 0.2 to insure that no confounding variable was missed
in the adjustment. For continuous variables, an analysis of variance (ANOVA) was initially
used to assess differences between BD-NOS, BD-I, and no BSD groups. A generalized
linear model (PROC GLM) was used to yield quantitative estimates of differences in mean,
with 95% confidence intervals, and conduct covariate-adjusted analyses. Effect sizes
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(Cohen’s d) were calculated to assess quantitative differences on clinical scales between
groups (39).For categorical variables, chi-square tests were used to determine unadjusted
differences between BD-NOS, BD-I, and no BSD groups. Covariate-adjusted differences
were conducted using PROC GENMOD (log link, binomial distribution). PROC GENMOD
also yielded quantitative estimates of differences (prevalence ratios), with 95% confidence
intervals. When adjusted models did not converge (due to small numbers in a particular
cell), unadjusted models were used. To determine whether observed differences between
youth with and without BSD were due to the ESM− youth in the latter group, we re-ran
analyses excluding those children without ESM. We also assessed the reasons that youth
with BD-NOS did not meet criteria for manic episodes, and were thus not classified as BD-I.
To avoid inflating the type II error risk, results were generally not corrected for multiple
corrections. However, to better assess differences in manic symptomatology between BD-
NOS versus BD-I, we indicate which of the uncorrected p-values would retain significance
upon correction for multiple comparisons using the false discovery rate (FDR) correction.
Results
Demographics
Of the 707 study participants, 71 met criteria for BD-I, 88 for BD-NOS (11 of whom also
satisfied DSM-IV criteria for cyclothymic disorder), and 3 for BD-II at intake; 545 did not
meet criteria for a BSD. Because of the small number of youth with BDI-II, these
participants were excluded from further analyses, leaving a total of 704 participants for the
analyses below.
Basic demographic characteristics of the study population are shown in Table 1. Youth with
BSD were slightly older than those without a bipolar diagnosis (p = 0.01); there was no
difference in age between the youth with BD-NOS and those with BD-I. There was also no
significant difference between the BD-NOS and BD-I groups in regards to the duration or
onset date of BSD. Two-thirds (68%) of the overall cohort were male; however, the BD-
NOS group had a lower percentage of males than the no BSD group (51% versus 71%).
Both race and parental employment status differed across diagnosis. Children with BD-I
were more likely to be white and have at least one employed parent compared to those with
BD-NOS or no BSD. One-third (32%) of all participants were living with both natural
parents; this proportion did not differ across diagnostic groups.
Symptom severity and functional impairment
Both BD-NOS and BD-I groups had more mood symptoms at baseline than the children
with no BSD, as measured by the KDRS, KMRS, YMRS, and CDRS-R at intake (all p <
0.0001) (Table 2). Interestingly, these scores did not differ between youth with BD-NOS
and those with BD-I at baseline. When comparing symptom severity during the most severe
episode, youth with BD-NOS had lower KMRS scores compared to those with BD-I, while
both groups had significantly elevated scores compared to youth with no BSD.
A similar pattern was seen with estimates of global function, as quantified by the CGAS. At
baseline, both BD-NOS and BD-I groups had impaired function, as compared to the children
with no BSD (p < 0.0001). However, when asked about the most severe period, children
with BD-NOS were significantly less impaired than those with BD-I, while both groups
were significantly more impaired than those with no BSD.
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Rates of comorbidity were quite high in this clinically recruited cohort (Table 3). ADHD
showed the highest rate of comorbidity. Two-thirds of the cohort had this diagnosis; rates
did not differ across diagnostic groups. Anxiety was found in 29% of our cohort; again, rates
did not differ across groups. Disruptive behavioral disorders were also very common,
particularly ODD, which was found in 37% of the cohort. Conduct disorder was more
common in those with BD-NOS and BD-I, as opposed to no BSD. ODD was less common
in the BD-I group, as compared to both BD-NOS and no BSD. Pervasive developmental
disorder was fairly rare in this sample (6%), and no youth with BD-NOS were found to have
this disorder.
Phenomenology and treatment history
Table 3 shows associated severe phenomenological features. Approximately 19% of the
youth in this cohort had a history of suicidal ideation, while 2% had associated behavior or
attempts. Youth with BD-I (but not BD-NOS) were more likely to have a history of suicidal
ideation and attempts than those with no BSD, and were more likely to have been
hospitalized psychiatrically. Both BD-NOS and BD-I groups were more likely to have
psychotic features than those without BSD, although these features were less common in
youth with BD-NOS than BD-I. Interestingly, only a minority of youth in this cohort had
ever met criteria for a major depressive episode (15%), and this percentage did not differ
significantly across groups.
Children with BD-I (but not those with BD-NOS) were more likely to have been medicated,
either currently or in the past, than those without BSD (Table 3). Stimulants were the most
common medication (57%), followed by antipsychotics (27%), antidepressants (20%),
alpha-2 agonists (15%), and mood stabilizers (13%). Not surprisingly, antipsychotics and
mood stabilizers were less commonly prescribed to those with BD-NOS versus BD-I, but
both groups had higher rates of prescriptions than those without BSD (p < 0.0001). Youth
with BD-I (but not those with BD-NOS) showed elevated rates of lifetime stimulants and
alpha-2 agonists, as compared to those with no BSD. No differences in rates of lifetime
antidepressant use were seen across groups.
Family history
Table 4 shows the proportion of children whose parent(s) have a psychiatric diagnosis. Rates
of parental history were the highest for depression (63%) and anxiety (43%) and did not
differ between the three diagnostic groups. Parental history of mania was reported in 20% of
the children. Children with BD-NOS and BD-I were more likely than children without a
BSD to have at least one parent with history of a manic episode (p = 0.0001); this proportion
did not differ significantly between those with BD-NOS vs. BD-I (33% versus 42%).
Children with BD-NOS were more likely than those with no BSD to have a parental history
positive for conduct disorder and for psychosis; no other between group differences were
detected.
Sensitivity analyses
It is possible that the observed differences between youth with and without BSD were driven
by differential degree of ESM across bipolar diagnosis, particularly if ESM− youth were less
impaired than ESM+ participants. While 86% (466/545) of the youth with no BSD were
ESM+, the ESM+ rate was higher among those with BSD. Ninety-eight percent (86/88) of
those with BD-NOS and 93% (66/71) of those with BD-I were ESM+. However, analyses
excluding ESM−youth revealed qualitatively similar differences between youth with and
without BSD (see Tables 1–4).
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Manic symptoms in BD-I versus BD-NOS
Table 5 shows the frequency with which manic symptoms were endorsed during the most
severe lifetime manic episode. In general, symptoms were endorsed less frequently by youth
with BD-NOS, as compared to those with BD-I. However, while these differences were
statistically significant in some cases, their absolute value was fairly small. Decreased need
for sleep showed the greatest difference across diagnostic categories; 41% of those with BD-
NOS reported this symptom compared to 66% of youth with BD-I. Of note, while irritability
was a frequently occurring symptom, it was less common in youth with BD-NOS vs. BD-I
(73% versus 92%). The proportion of youth with elated mood was high in both groups, and
did not differ statistically across diagnosis. After adjusting for multiple comparisons (using
FDR correction), irritability, decreased need for sleep, poor judgment, and distractibility
retained significance at the corrected p < 0.05 level. Limiting the analysis to moderate or
severe symptoms yielded qualitatively similar results (not shown in table).
Reasons for the BD-NOS diagnosis
The most common reason that BD-NOS youth did not meet criteria for a manic episode was
insufficient duration of symptoms. Eighty-six of the 88 BD-NOS participants (98%) had
episodes lasting less than the seven-day requirement for mania. The degree to which BD-
NOS youth met the symptom criteria for mania (elevated mood plus three associated
symptoms, or irritable mood plus four associated symptoms) depended on the threshold
used. Using a mild threshold for all DSM-IV symptoms, 71/88 (81%) met symptom criteria
for a manic/hypomanic episode; using a moderate threshold, only 21/82 (24%) met symptom
criteria. A small minority of the BD-NOS youth (6/88, 7%) met both symptom and duration
criteria for hypomania, but had also had marked impairment during these episodes (which is
an exclusion criterion for hypomania in DSM-IV-TR). Of these six youth, only one had a
history of a major depressive episode, and would thus have met criteria for BD-II (were it
not for the marked impairment during the period of abnormally elevated/irritable mood).
Discussion
This well-characterized clinical cohort provides an ideal study population to assess the
diagnostic boundaries of bipolar disorder in youth. Previous clinical samples that assessed
this issue have been samples referred with suspicion of a bipolar or mood disorder diagnosis
(e.g., COBY) (11–13, 33, 40). In contrast, this study includes participants who presented at
outpatient psychiatric clinics, and were recruited based on a dimensional measure of manic
symptomatology. Thus it includes a large number of children who have non-specific manic
symptoms that could be attributable to a variety of psychopathologies, and can be compared
to those with episodic mood symptoms on the bipolar spectrum. This design allows us not
only to compare the clinical characteristics and family history of participants with a
diagnosis of BD-NOS and BD-I, but it also facilitates a comparison between those with and
without BSD.
These analyses of the baseline LAMS data reveal many similarities between BD-NOS and
BD-I youth, which are not shared by the clinically recruited sample without BSD, most of
whom also scored high on the PGBI-10M. Indicators of baseline impairment (CGAS,
KMRS, KDRS, YMRS, and CDRS-R) did not differ significantly between BD-NOS and
BD-I groups, but were more severe in these youth compared to those with no BSD.
Similarly, both BD-NOS and BD-I groups had an elevated parental history of mania, which
was not shared by those with no BSD. Prevalence of conduct disorder was similar in the
BD-NOS and BD-I groups, but elevated relative to the group without BSD. In contrast,
indicators of most severe past functioning showed a gradient according to disorder, with
significant differences in both worst lifetime CGAS and KMRS scores across groups, as
Hafeman et al. Page 7













well as the lifetime presence of psychotic features (BD-I > BD-NOS > no BSD). Finally,
certain indicators of very severe dysfunction, such as suicidal ideation, suicidal behavior,
and history of hospitalization were elevated in the BD-I group, but not the BD-NOS group
(as compared to those without BSD). The latter is not surprising, given that psychiatric
hospitalization is part of the DSM-IV criteria for a manic episode (34). Excluding the ESM−
participants did not qualitatively change results, indicating that differences between those
with and without BSD were not driven by the youth without manic symptoms.
Comparison between the clinical presentation of BD-NOS and BD-I also indicates many
similarities. BD-NOS and BD-I youth had a similar age of onset and duration of BSD.
Additionally, manic symptoms did not differ extensively between BD-NOS and BD-I.
Several manic symptoms were significantly more likely to be present in participants with
BD-I than with BD-NOS: irritable mood, decreased need for sleep, distractibility, racing
thoughts, flight of ideas, and poor judgment. However, similar to findings from the COBY
study (24), effect sizes were small and did not reflect qualitatively different episodes.
Interestingly, the current results do not indicate a significant difference in the proportion of
BD-NOS versus BD-I with elated mood, and youth with BD-NOS are less likely to be
irritable than those with BD-I. Thus, it is unlikely that the BD-NOS presentation is a variant
of the chronic irritability described by previous authors (41). These results are consistent
with data from Van Meter et al. that showed high levels of irritability in youth with
cyclothymia and BD-NOS (as compared with ADHD and depression), but slightly lower
relative to BD-I and BD-II (42).
The above findings are consistent with the interpretation that BD-NOS and BD-I share
similar characteristics, and are along a spectrum of bipolarity, while youth without distinct
episodes of manic symptoms do not seem to share many of these characteristics. However,
as would be expected, youth with BD-I are more likely than those with BD-NOS to have
more severe past presentations, with worse functional impairment during the most serious
lifetime episode, as well as an increased rate of hospitalizations and suicidality. These
results are remarkably consistent with the COBY data, which also showed no significant
difference between BD-NOS and BD-I on many factors (such as family history and
comorbidity), though there were differences on indicators of severe illness (hospitalization,
psychosis, and suicide attempts) (24). Findings are also consistent with other groups that
have found an elevated family history of mania in youth with both syndromal and sub-
syndromal BD, but not major depressive disorder (11, 18).
This study indicates a high degree of comorbidity in this cohort, similar to previous work,
particularly in pediatric samples. ADHD and ODD are the most common disorders in this
cohort, with 2/3 of youth meeting diagnostic criteria for ADHD and 1/3 for ODD. These are
comparable to previous clinical samples (2, 24, 43), but are higher than co-morbidities seen
in epidemiologic samples (18, 44). Rates of ADHD and anxiety did not differ across bipolar
diagnostic category, consistent with prior results (11, 44). However, the disruptive
behavioral disorders showed an interesting pattern of results. Both BD-NOS and BD-I
groups had a higher frequency of conduct disorder, as compared to the group with no BSD.
This is consistent with previous research, which has shown elevated conduct disorder and
criminal activity in youth and adults on the bipolar spectrum (6, 46). In contrast, ODD was
found to be less common in the BD-I group, as compared to both those with BD-NOS and
those without BSD. This result was unexpected, has not been found in COBY or other
similar studies, and is difficult to interpret. One possible explanation is that, with the
lengthier and more discrete episodes that define BD-I (as opposed to BD-NOS), it is easier
to distinguish whether symptoms of oppositionality and defiance were associated with mood
episodes versus the more chronic pattern that occurs with a diagnosis of ODD.
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The vast majority of BD-NOS youth in this cohort failed to meet duration criteria for mania
or hypomania, similar to findings from the COBY study (24). However, a sizeable minority
of BD-NOS youth also failed to meet symptom criteria for a manic episode, which is in
contrast to the COBY study sample (where 99.6% of the BD-NOS youth met symptom
criteria). These differences are likely attributable to differences in recruiting strategies, since
COBY youth were referred based on the suspicion of having bipolar disorder. Thus it is not
surprising that almost all of the BD-NOS youth in COBY met symptom criteria.
A number of limitations should be taken into account when interpreting these data. First, this
is a clinically derived sample, and thus is not necessarily characteristic of youth in the
community. Additionally, these youth were recruited from clinics associated with major
medical centers in Western Pennsylvania and Ohio, so they might not be representative of
other regions of the country. Second, analyses focused on the baseline data from the LAMS
study, and as with any cross-sectional analysis, there are limitations when interpreting the
causality of observed associations. Longitudinal data are currently being collected, and will
likely yield valuable insights regarding clinical trajectory and biomarkers distinguishing
youth with subsyndromal presentations of BD. It also is important to note that we included
cyclothymic disorder with BD-NOS. The combined operational definition is consistent with
much prior research (11, 45) and facilitates comparison across studies as well as providing
larger n for statistical analyses. However, it is possible that cyclothymic disorder may have
some different clinical features from other presentations included in the NOS category (13,
14). Finally, although the LAMS study has a large sample size, the number of youth with
BD-NOS or BD-I is a smaller proportion of the population, and thus we might not have the
power to detect small differences, particularly between BD-NOS and BD-I. We did not have
a sufficient number of cases with BD-II to permit statistical analyses.
The existing literature and the current results indicate that BD-NOS and BD-I are on a
spectrum of bipolarity that share clinical characteristics, phenomenology, and family history
of mania, and that these characteristics are not shared by youth with less episodic mood
symptoms. The differences seen between those with and without BSD are especially
striking, given that the majority of this cohort (including those with no BSD) was selected to
have ESM. Thus, this analysis provides evidence for qualitative differences between those
with episodic versus non-episodic manic symptoms, even when the episodes are too short to
meet duration criteria for mania or hypomania.
While this is a cross-sectional analysis, it provides important insight into the appropriate
diagnostic boundaries of bipolar disorder in youth, which will likely have implications for
prognosis and treatment. These results support the hypothesis that current duration criteria in
the DSM-IV-TR are perhaps too stringent, given the evidence that youth with even short
manic episodes might have an underlying bipolar diathesis. If supported by future
longitudinal analyses, this has important implications for diagnostic criteria in future
versions of the DSM. These findings also highlight the clinical importance of assessing
subsyndromal manic symptoms in pediatric populations, even if they don’t meet full
syndromal criteria for BD-I or BD-II, and the need to develop appropriate treatments for
these youth. Future work will determine the clinical trajectory of these participants, as well
as seek to identify neuroimaging and neurocognitive biomarkers of progression.
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